Cancer research often involves complex clinical trials due to the heterogeneity of the disease and its various stages. By adhering to ICH E9 guidelines, researchers can ensure that their trials are methodologically sound, thus enhancing the reliability of their findings. This is especially critical in cancer research, where the stakes are high, and treatment decisions can significantly impact patient outcomes.
